• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small cell lung cancer with a PD-L1 expression level of >/= 1% by the U.S. Food and Drug Administration

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Mountzios, G
    Remon, J
    Novello, S
    Blais, N
    Califano, Raffaele
    Cufer, T
    Dingemans, A
    Liu, SV
    Peled, N
    Pennell, NA
    Reck, M
    Rolfo, C
    Tan, D
    Vansteenkiste, J
    West, H
    Besse, B
    Show allShow less
    Affiliation
    Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece
    Issue Date
    2019
    
    Metadata
    Show full item record
    Citation
    Mountzios G, Remon J, Novello S, Blais N, Califano R, Cufer T, et al. Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small cell lung cancer with a PD-L1 expression level of >/= 1% by the U.S. Food and Drug Administration. Ann Oncol. 2019 Sep 3.
    Journal
    Annals of Oncology
    URI
    http://hdl.handle.net/10541/622191
    DOI
    10.1093/annonc/mdz295
    PubMed ID
    31504132
    Additional Links
    https://dx.doi.org/10.1093/annonc/mdz295
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1093/annonc/mdz295
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50.
    • Authors: Descourt R, Chouaid C, Pérol M, Besse B, Greillier L, Bylicki O, Ricordel C, Guisier F, Gervais R, Schott R, Auliac JB, Robinet G, Decroisette C
    • Issue date: 2021 Aug
    • FDA Approves 2 Therapies for Treatment of Metastatic Non-Small Cell Lung Cancer.
    • Authors: Wright KM
    • Issue date: 2020 Jun 10
    • Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.
    • Authors: Aguilar EJ, Ricciuti B, Gainor JF, Kehl KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo S, Khosrowjerdi S, Peterson RM, Digumarthy S, Liu C, Sauter J, Rizvi H, Arbour KC, Carter BW, Heymach JV, Altan M, Hellmann MD, Awad MM
    • Issue date: 2019 Oct 1
    • Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater.
    • Authors: She L, Hu H, Liao M, Xia X, Shi Y, Yao L, Ding D, Zhu Y, Zeng S, Shen L, Huang J, Carbone DP
    • Issue date: 2019 Dec
    • Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung Cancer.
    • Authors: Huang M, Pietanza MC, Samkari A, Pellissier J, Burke T, Chandwani S, Kong F, Pickard AS
    • Issue date: 2019 Jan
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.